The Connexin Connection

Biologists are vigorously and enthusiastically exploring the structure and function of channels known as connexins, which link cells to one another. Connexin research is "hot," says one scientist heavily involved in the field, as investigators seek to answer a host of questions ranging from what passes through these channels to when and why they appear and disappear. Understanding how these channels work may also lead to improved drugs for diseases linked with connexin mutations. "From my perspe

Written byHarvey Black
| 6 min read

Register for free to listen to this article
Listen with Speechify
0:00
6:00
Share

Biologists are vigorously and enthusiastically exploring the structure and function of channels known as connexins, which link cells to one another. Connexin research is "hot," says one scientist heavily involved in the field, as investigators seek to answer a host of questions ranging from what passes through these channels to when and why they appear and disappear. Understanding how these channels work may also lead to improved drugs for diseases linked with connexin mutations. "From my perspective, what has made connexins hot is their association with a number of human diseases. We now have good evidence that mistakes in connexin genes underlie these disorders," says Alan Shiels, assistant professor of ophthalmology and genetics at Washington University. Shiels is studying the link between connexin mutations and inherited cataracts.

Daniel Goodenough, professor of cell biology at Harvard Medical School, whose recent research points to a possible link between connexin mutations and female ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies